Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
Neoantigens determine anti-cancer immunoreactivity and are important functional targets for immunotherapy. Here, the authors use deep mass spectrometry to characterize neoepitopes from human melanoma tissue and show the presence of tumour-reactive T cells with specificity for selected neoantigens.
Main Authors: | Michal Bassani-Sternberg, Eva Bräunlein, Richard Klar, Thomas Engleitner, Pavel Sinitcyn, Stefan Audehm, Melanie Straub, Julia Weber, Julia Slotta-Huspenina, Katja Specht, Marc E. Martignoni, Angelika Werner, Rüdiger Hein, Dirk H. Busch, Christian Peschel, Roland Rad, Jürgen Cox, Matthias Mann, Angela M. Krackhardt |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2016-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms13404 |
Similar Items
-
Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients
by: Eva Bräunlein, et al.
Published: (2017-11-01) -
Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat Cancer
by: Stefan Audehm, et al.
Published: (2019-06-01) -
Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope
by: Hakimeh Ebrahimi-Nik, et al.
Published: (2021-11-01) -
The neoepitope landscape of breast cancer: implications for immunotherapy
by: Pooja Narang, et al.
Published: (2019-03-01) -
Non-Hodgkin Lymphoma Secondary to Hodgkin Lymphoma in an Adult Patient With Nijmegen Breakage Syndrome
by: Krischan Braitsch, et al.
Published: (2018-10-01)